The two new nuclear reactors under construction at Georgia Power’s Plant Vogtle. (The Center Square) – The U.S. Senate passed legislation Tuesday which adjusts the NRC’s role in the advancement of nuclear power in the United States by streamlining the Nuclear Regulatory Commission’s licensing process for reactor construction.
“By modernizing the licensing and approval processes at the NRC, the legislation could potentially accelerate the design and domestic commercialization of standardized reactors to address various applications”, the Citizens for Responsible Energy Solutions Forum wrote in a May press release.
The bill passed the House and Senate with broad, bipartisan support and is now on its way to President Biden’s desk to become law.
To make reactor construction more achievable, the bill reduces the fees the Nuclear Regulatory Commission charges to developers while accelerating the licensing process for new reactors and staffing.The bill has its critics, however.The Union of Concerned Scientists released a statement […]
— Read More: www.thecentersquare.com
What Would You Do If Pharmacies Couldn’t Provide You With Crucial Medications or Antibiotics?
The medication supply chain from China and India is more fragile than ever since Covid. The US is not equipped to handle our pharmaceutical needs. We’ve already seen shortages with antibiotics and other medications in recent months and pharmaceutical challenges are becoming more frequent today.
Our partners at Jase Medical offer a simple solution for Americans to be prepared in case things go south. Their “Jase Case” gives Americans emergency antibiotics they can store away while their “Jase Daily” offers a wide array of prescription drugs to treat the ailments most common to Americans.
They do this through a process that embraces medical freedom. Their secure online form allows board-certified physicians to prescribe the needed drugs. They are then delivered directly to the customer from their pharmacy network. The physicians are available to answer treatment related questions.
